Lachaine, J.; Beauchemin, C.; Guinan, K.; Thebault, P.; Aw, A.; Banerji, V.; Fleury, I.; Owen, C.
Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada. Curr. Oncol. 2021, 28, 332-345.
https://doi.org/10.3390/curroncol28010037
AMA Style
Lachaine J, Beauchemin C, Guinan K, Thebault P, Aw A, Banerji V, Fleury I, Owen C.
Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada. Current Oncology. 2021; 28(1):332-345.
https://doi.org/10.3390/curroncol28010037
Chicago/Turabian Style
Lachaine, Jean, Catherine Beauchemin, Kimberly Guinan, Philippe Thebault, Andrew Aw, Versha Banerji, Isabelle Fleury, and Carolyn Owen.
2021. "Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada" Current Oncology 28, no. 1: 332-345.
https://doi.org/10.3390/curroncol28010037
APA Style
Lachaine, J., Beauchemin, C., Guinan, K., Thebault, P., Aw, A., Banerji, V., Fleury, I., & Owen, C.
(2021). Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada. Current Oncology, 28(1), 332-345.
https://doi.org/10.3390/curroncol28010037